ENTA - Enanta Pharmaceuticals Inc. (ENTA) CEO Dr. Jay Luly on Q4 Fiscal 2021 Result - Earnings Call Transcript
Enanta Pharmaceuticals, Inc. (ENTA) Q4 2021 Earnings Conference Call November 22, 2021 04:30 AM ET Company Participants Dr. Jay Luly – President and Chief Executive Officer Jennifer Viera – Investor Relations Paul Mellett – CFO Nathalie Adda – Chief Medical Officer Conference Call Participants Brian Abrahams – RBC Capital Markets Akash Tewari – Jefferies Unidentified Analyst 1 – Piper Sandler Brian Skorney – Baird Roy Buchanan – JMP Securities Eric Joseph – JP Morgan Zegbeh Jallah – Roth Capital Partners Unidentified Analyst 2 – Analyst Lisa Vago – Evercore Presentation Operator Good afternoon. And welcome to Enanta Pharmaceuticals Fiscal Fourth Quarter and year-end 2021 financial results conference call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end of the prepared remarks. Please be advised that this call is being recorded. I would now like to turn the call over to
For further details see:
Enanta Pharmaceuticals, Inc. (ENTA) CEO Dr. Jay Luly on Q4 Fiscal 2021 Result - Earnings Call Transcript